Upadacitinib Delivers Durable 1-Year Benefits in Real-World UC
(MedPage Today) -- LAS VEGAS -- Upadacitinib (Rinvoq) demonstrated durable clinical, endoscopic, and histologic benefit in a large real-world cohort ...
Tag: Upadacitinib
Upadacitinib Shows 1-Year Benefit in Pediatric IBD
(MedPage Today) -- LAS VEGAS -- Upadacitinib (Rinvoq) showed durable clinical benefit at 1 year among children and adolescents with ...